Oral Vaccine Based on U-Omp19 Protects Mice Against Brucella Infection
Author Information
Author(s): Pasquevich Karina A., Ibañez Andrés E., Coria Lorena M., García Samartino Clara, Estein Silvia M., Zwerdling Astrid, Barrionuevo Paula, Oliveira Fernanda S., Seither Christine, Warzecha Heribert, Oliveira Sergio C., Giambartolomei Guillermo H., Cassataro Juliana
Primary Institution: Universidad de Buenos Aires (UBA), Buenos Aires, Argentina
Hypothesis
Can an oral vaccine based on U-Omp19 induce protection against Brucella abortus infection in mice?
Conclusion
The study found that an oral vaccine based on U-Omp19 induces protection against Brucella abortus by eliciting an adaptive IL-17 immune response.
Supporting Evidence
- U-Omp19 formulations induced protection against Brucella when orally administered without the need of adjuvants.
- IL-17A neutralization during the challenge period abrogated the vaccine's protective effect.
- U-Omp19 activated dendritic cells in vivo, indicating its potential as a self-adjuvant.
Takeaway
Researchers created a vaccine from a protein called U-Omp19 that can be given to mice by mouth, and it helps them fight off a type of bacteria that can make them sick.
Methodology
Mice were immunized with U-Omp19 via oral and parenteral routes, and their immune responses were evaluated after challenging them with virulent Brucella.
Limitations
The study was conducted in mice, and results may not directly translate to other species.
Participant Demographics
8-10 week-old female specific-pathogen-free mice.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website